oxybutynin has been researched along with Grippe in 6 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| " HD-MAP vaccination was safe and well tolerated; any systemic or local adverse events (AEs) were mild or moderate." | 2.94 | Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. ( Bodle, J; Depelsenaire, ACI; Fernando, GJP; Forster, AH; Francis, B; Hickling, J; Lickliter, JD; Pryor, M; Rockman, S; Treasure, P; Veitch, M; Wells, JW; Wheatley, A; Witham, K, 2020) |
| "Whole inactivated influenza virus vaccine (A/Puerto Rico/8/34) was formulated into dissolving microneedle patches and vaccine stability was evaluated by in vitro and in vivo assays of antigenicity and immunogenicity after storage for up to 3 months at 4, 25, 37 and 45°C." | 1.43 | Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches. ( Chu, LY; Compans, RW; Dong, K; Prausnitz, MR; Yang, C; Ye, L, 2016) |
| "Prevention of seasonal influenza epidemics and pandemics relies on widespread vaccination coverage to induce protective immunity." | 1.42 | Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. ( Compans, RW; Esser, ES; Kalluri, H; McAllister, D; Pewin, WP; Prausnitz, MR; Pulit-Penaloza, JA; Skountzou, I; Taherbhai, MT; Vassilieva, EV, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Forster, AH | 1 |
| Witham, K | 1 |
| Depelsenaire, ACI | 1 |
| Veitch, M | 1 |
| Wells, JW | 1 |
| Wheatley, A | 1 |
| Pryor, M | 1 |
| Lickliter, JD | 1 |
| Francis, B | 1 |
| Rockman, S | 1 |
| Bodle, J | 1 |
| Treasure, P | 1 |
| Hickling, J | 1 |
| Fernando, GJP | 1 |
| Trilla, A | 1 |
| Norman, JJ | 1 |
| Arya, JM | 1 |
| McClain, MA | 1 |
| Frew, PM | 1 |
| Meltzer, MI | 1 |
| Prausnitz, MR | 3 |
| Vassilieva, EV | 1 |
| Kalluri, H | 1 |
| McAllister, D | 1 |
| Taherbhai, MT | 1 |
| Esser, ES | 1 |
| Pewin, WP | 1 |
| Pulit-Penaloza, JA | 1 |
| Compans, RW | 2 |
| Skountzou, I | 1 |
| Hirobe, S | 1 |
| Azukizawa, H | 1 |
| Hanafusa, T | 1 |
| Matsuo, K | 1 |
| Quan, YS | 1 |
| Kamiyama, F | 1 |
| Katayama, I | 1 |
| Okada, N | 1 |
| Nakagawa, S | 1 |
| Chu, LY | 1 |
| Ye, L | 1 |
| Dong, K | 1 |
| Yang, C | 1 |
2 trials available for oxybutynin and Grippe
| Article | Year |
|---|---|
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Antibodies, Viral; Australia; Cells, Cultured; Drug St | 2020 |
Microneedle patches: usability and acceptability for self-vaccination against influenza.
Topics: Adult; Female; Humans; Influenza Vaccines; Influenza, Human; Injections, Intradermal; Male; Middle A | 2014 |
4 other studies available for oxybutynin and Grippe
| Article | Year |
|---|---|
Influenza intradermal vaccine (soluble microneedles): A patch, a solution….
Topics: Equipment Design; Humans; Influenza Vaccines; Influenza, Human; Injections, Intradermal; Needles; Tr | 2018 |
Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Topics: Animals; Antigens, Viral; Drug Delivery Systems; Drug Stability; Female; Humans; Immunity, Humoral; | 2015 |
Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Topics: Administration, Cutaneous; Adult; Animals; Antibody Formation; Chickens; Hemagglutinins; Humans; Hya | 2015 |
Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Topics: Animals; Drug Delivery Systems; Drug Storage; Hot Temperature; Humans; Immunization; Influenza A Vir | 2016 |